Medtronic Debuts Medical Device in U.S. Designed to Improve Treatment of Aortic Aneurysms
Medtronic has announced the U.S. launch of the Talent Abdominal Stent Graft on the Xcelerant Hydro Delivery System. EVAR is a treatment for aortic aneurysm, a bulge or weakening in the body’s main artery that can rupture with fatal consequences if left untreated. EVAR involves the navigation of a stent graft, via the body’s arteries, to the aorta. The stent graft is then deployed to create a tube within the aorta, reducing pressure on the aneurysm and the risk of rupture. EVAR is a minimally-invasive alternative to open surgical repair.
-
FDA okays expanded offering of Powerlink stent graft products
FDA nod to Endologix’s IntuiTrak™ Delivery System
New NICE Guidance Will Improve Diagnosis And Treatment Of Chronic Heart Failure
ES Vascular gets CE Marking for OAS system
St. Jude Medical Announces Japanese Approval Of The Therapy Cool Path Ablation Catheter
